Hosted on MSN7mon
Drug manufacturer Eli Lilly says two of its diabetes drugs are in short supply - as millions of patients face weeks of chaos
Eli Lilly has not said why it is seeing this shortage The shortage will only affect vials of insulin, not the pens, which doctors hope will help alleviate some of the panic people may be experiencing.
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...
$35 insulin: Who in the US benefits?
Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...
pharmaphorum15d
Lilly preps for rollout of its connected diabetes system
The Tempo pen is currently compatible with three of Lilly's insulin products, including Humalog and Lyumjev, both insulin lispro-based, and insulin glargine brand Basaglar. "Despite technological ...
As insulin shortages persist, what diabetes patients can do
Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...
Austin American-Statesman12d
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
An Eli Lilly official said decades of insulin research ... more than a dozen insulin products and more than 800 million insulin pens a year. "Not only are we not winding down our work for people ...